Bulk Tesamorelin 10MG X 10 Vials

Bulk Tesamorelin 10MG x 10 Vials

Tesamorelin is a synthetic peptide that mimics the growth hormone-releasing hormone (GHRH). The bulk form available as ten 10 mg vials offers researchers and clinicians a convenient, cost-effective way to study its effects on adipose tissue reduction, metabolic regulation, and potential therapeutic applications. Each vial contains a high-purity powder that can be reconstituted with sterile diluents for precise dosing.

Tesamorelin Structure

The molecular backbone of Tesamorelin consists of 44 amino acids arranged in a linear sequence that closely resembles native GHRH but incorporates several substitutions to enhance stability and receptor affinity. Key residues include an N-terminal pyroglutamate, which protects against degradation, and strategically placed D-alanine residues that resist peptidase activity. The peptide adopts a compact helical conformation when bound to its receptor, facilitating efficient signal transduction in the pituitary gland.

Additional Information

Clinical studies have shown that Tesamorelin reduces visceral adiposity in patients with HIV-associated lipodystrophy while sparing subcutaneous fat. Beyond metabolic benefits, research suggests potential roles in cardiovascular health, neuroprotection, and anti-aging therapies. The bulk formulation allows dose titration for preclinical models, enabling exploration of pharmacokinetics, biodistribution, and safety profiles.

Peptide Storage

To preserve potency, Tesamorelin should be stored at −20 °C or colder once reconstituted, although the dry powder can remain stable at 2–8 °C for up to 24 months. Protect the peptide from light and moisture by using airtight containers and avoiding repeated freeze-thaw cycles. When preparing solutions, use sterile, pyrogen-free water for injection and follow aseptic technique to prevent contamination.

Lab Report

In a recent pharmacodynamic study, a cohort of ten mice received daily subcutaneous injections of 0.5 mg/kg Tesamorelin over four weeks. Results demonstrated significant reductions in abdominal fat mass (35% decrease) without changes in lean body weight. Serum insulin sensitivity improved by 20%, and liver enzyme levels remained within normal ranges, indicating a favorable safety profile at the administered dose.

Reviews

Users of bulk Tesamorelin report consistent purity and potency across batches. Many researchers highlight the peptide’s ease of reconstitution and rapid onset of action. However, some note that high doses can lead to mild edema or transient headaches in sensitive individuals. Overall satisfaction rates remain above 90%, with many citing its versatility for both metabolic research and therapeutic trials.